Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein.
Development of multidrug resistance (MDR) is a continuous clinical challenge partially due to the overexpression of P-glycoprotein (P-gp) for chronic myelogenous leukemia (CML) patients. Herein, we evaluated the inhibitory potency of emodin, a natural anthraquinone derivative isolated from Rheum pal...
Үндсэн зохиолчид: | Hongping Min, Miaomiao Niu, Weilin Zhang, Jia Yan, Jiachang Li, Xiying Tan, Bo Li, Mengxiang Su, Bin Di, Fang Yan |
---|---|
Формат: | Өгүүллэг |
Хэл сонгох: | English |
Хэвлэсэн: |
Public Library of Science (PLoS)
2017-01-01
|
Цуврал: | PLoS ONE |
Онлайн хандалт: | http://europepmc.org/articles/PMC5679605?pdf=render |
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo.
-н: Zheyi Hu, зэрэг
Хэвлэсэн: (2015-01-01) -
Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein
-н: Jerónimo Laiolo, зэрэг
Хэвлэсэн: (2024-01-01) -
Neuroprotection of Emodin by Inhibition of Microglial NLRP3 Inflammasome-Mediated Pyroptosis
-н: Wen Jiang, зэрэг
Хэвлэсэн: (2023-03-01) -
Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo
-н: Gangyang Wang, зэрэг
Хэвлэсэн: (2022-01-01) -
Swietephragmin D, a limonoid from Swietenia mahagoni, reverses multidrug resistance by inhibiting P-glycoprotein dependent efflux
-н: Han Guo, зэрэг
Хэвлэсэн: (2022-05-01)